2023
DOI: 10.1177/27550834231167049
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of community pharmacists’ knowledge of the differences between generic drugs and biosimilars: A pilot cross-sectional study

Abstract: Background: Pharmacists’ knowledge of the differences in the characteristics between generic drugs and biosimilars is essential to ensure good practice and lower pharmaceutical bills. Objectives: This study aimed to evaluate community pharmacists’ knowledge and perception of using and substituting biosimilars and generic drugs. Design: A pilot cross-sectional study was performed over 2 months (August-September 2022) targeting community pharmacists in their work site. Method: Data were collected using a uniform… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 31 publications
(37 reference statements)
0
1
0
Order By: Relevance
“…Overall, participants expressed good knowledge about generic drugs in agreement with a recently published study. 27 Most participants knew that generic drugs must be in the same dosage and form as their brands. This knowledge is significantly higher among pharmacists than physicians, 23 highlighting their role as key stakeholders in lowering pharmaceutical expenditures.…”
Section: Discussionmentioning
confidence: 99%
“…Overall, participants expressed good knowledge about generic drugs in agreement with a recently published study. 27 Most participants knew that generic drugs must be in the same dosage and form as their brands. This knowledge is significantly higher among pharmacists than physicians, 23 highlighting their role as key stakeholders in lowering pharmaceutical expenditures.…”
Section: Discussionmentioning
confidence: 99%